Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 9.77
-0.35 (-3.46%)
Nov 13, 2026, 3:04 PM CST
SHE:002082 Revenue
Wanbangde Pharmaceutical Holding Group had revenue of 165.09M CNY in the quarter ending September 30, 2026, a decrease of -62.41%. This brings the company's total for the last twelve months to 853.52M, down -38.44% year-over-year. In the year 2025, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.12B, down -22.59%. That makes Wanbangde Pharmaceutical Holding Group the 20,858th largest company in the world by revenue and 3,836th in China.
Revenue (ttm)
853.52M
Revenue Growth
-38.44%
P/S Ratio
7.00
Revenue / Employee
633.18K
Employees
1,348
Market Cap
5.98B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:002082 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | -326.04M | -22.59% |
| Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
| Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
| Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
| Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.